Ashwin A. Patkar

9.8k total citations
282 papers, 7.2k citations indexed

About

Ashwin A. Patkar is a scholar working on Psychiatry and Mental health, Pharmacology and Epidemiology. According to data from OpenAlex, Ashwin A. Patkar has authored 282 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Psychiatry and Mental health, 102 papers in Pharmacology and 55 papers in Epidemiology. Recurrent topics in Ashwin A. Patkar's work include Treatment of Major Depression (82 papers), Bipolar Disorder and Treatment (51 papers) and Neurotransmitter Receptor Influence on Behavior (46 papers). Ashwin A. Patkar is often cited by papers focused on Treatment of Major Depression (82 papers), Bipolar Disorder and Treatment (51 papers) and Neurotransmitter Receptor Influence on Behavior (46 papers). Ashwin A. Patkar collaborates with scholars based in United States, South Korea and Italy. Ashwin A. Patkar's co-authors include Chi‐Un Pae, Prakash S. Masand, Paolo Mannelli, Soo-Jung Lee, Alessandro Serretti, Stephen P. Weinstein, Sheng‐Min Wang, Li‐Tzy Wu, David M. Marks and Kathleen Peindl and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ashwin A. Patkar

278 papers receiving 6.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Ashwin A. Patkar	2.0k	1.8k	1.2k	1.1k	1.1k	282	7.2k
Brian Pittman	1.8k 0.9×	1.8k 1.0×	2.3k 1.8×	697 0.6×	590 0.5×	264	9.5k
Mark S. Gold	1.3k 0.6×	1.2k 0.6×	2.1k 1.7×	920 0.8×	858 0.8×	230	6.4k
A. Eden Evins	2.6k 1.3×	1.6k 0.9×	1.5k 1.2×	722 0.7×	625 0.6×	186	8.6k
John Rotrosen	3.7k 1.8×	1.0k 0.5×	2.5k 2.0×	1.7k 1.5×	1.4k 1.2×	282	10.4k
Alexander H. Glassman	1.7k 0.9×	1.6k 0.8×	841 0.7×	577 0.5×	801 0.7×	102	9.5k
Robert Malcolm	1.1k 0.6×	1.1k 0.6×	1.9k 1.5×	1.2k 1.1×	573 0.5×	140	6.0k
Ismene L. Petrakis	984 0.5×	1.2k 0.6×	2.5k 2.1×	1.5k 1.3×	430 0.4×	177	6.4k
Anne Lingford‐Hughes	1.4k 0.7×	2.0k 1.1×	2.9k 2.3×	1.2k 1.1×	385 0.3×	184	7.4k
David Mischoulon	2.4k 1.2×	2.2k 1.2×	637 0.5×	370 0.3×	1.1k 1.0×	323	11.6k
Michele Fornaro	3.9k 1.9×	1.3k 0.7×	561 0.5×	457 0.4×	758 0.7×	244	8.8k

Countries citing papers authored by Ashwin A. Patkar

Since Specialization

Citations

This map shows the geographic impact of Ashwin A. Patkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashwin A. Patkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashwin A. Patkar more than expected).

Fields of papers citing papers by Ashwin A. Patkar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashwin A. Patkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashwin A. Patkar. The network helps show where Ashwin A. Patkar may publish in the future.

Co-authorship network of co-authors of Ashwin A. Patkar

This figure shows the co-authorship network connecting the top 25 collaborators of Ashwin A. Patkar. A scholar is included among the top collaborators of Ashwin A. Patkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashwin A. Patkar. Ashwin A. Patkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Seung‐Hoon, Won‐Myong Bahk, Soo-Jung Lee, et al.. (2024). The Potential Role of Aripiprazole Augmentation for Major Depressive Disorder with Anxious Distress in Naturalistic Treatment Setting. Clinical Psychopharmacology and Neuroscience. 22(2). 370–375.

Lee, Kyung Ho, Won‐Myong Bahk, Soo-Jung Lee, et al.. (2023). Additional Clinical Benefit of Agomelatine Treatment for Major Depressive Disorder in Naturalistic Treatment Setting. Clinical Psychopharmacology and Neuroscience. 21(3). 594–598.

Kim, Junhyung, Hyun‐Ghang Jeong, Moon‐Soo Lee, et al.. (2023). Effect of Frailty on Depression among Patients with Late-life Depression: A Test of Anger, Anxiety, and Resilience as Mediators. Clinical Psychopharmacology and Neuroscience. 22(2). 253–262. 1 indexed citations

Shin, Cheolmin, Sang Won Jeon, Seung‐Hoon Lee, et al.. (2023). Efficacy and Safety of Escitalopram, Desvenlafaxine, and Vortioxetine in the Acute Treatment of Anxious Depression: A Randomized Rater-blinded 6-week Clinical Trial. Clinical Psychopharmacology and Neuroscience. 21(1). 135–146. 12 indexed citations

Lee, Seung‐Hoon, Sang Won Jeon, Cheolmin Shin, et al.. (2022). Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study. Psychiatry Investigation. 19(4). 268–280. 11 indexed citations

Martin, Matthew, et al.. (2021). SBIRT training: how do social work students compare to medical learners?. Social Work in Health Care. 60(10). 631–641. 2 indexed citations

Calabrò, Marco, Laura Mandelli, Concetta Crisafulli, et al.. (2018). Neuroplasticity, Neurotransmission and Brain-Related Genes in Major Depression and Bipolar Disorder: Focus on Treatment Outcomes in an Asiatic Sample. Advances in Therapy. 35(10). 1656–1670. 15 indexed citations

Shin, Cheolmin, Young‐Hoon Ko, Seoyoung Yoon, et al.. (2017). Sickness absence indicating depressive symptoms of working population in South Korea. Journal of Affective Disorders. 227. 443–449. 2 indexed citations

Pae, Chi‐Un, et al.. (2015). Vortioxetine: a meta-analysis of 12 short-term, randomized, placebo-controlled clinical trials for the treatment of major depressive disorder. Journal of Psychiatry and Neuroscience. 40(3). 174–186. 52 indexed citations

10.

Wang, Sheng‐Min, Masaki Kato, Soo-Jung Lee, et al.. (2013). Second-generation antipsychotics in the treatment of major depressive disorder: current evidence. Expert Review of Neurotherapeutics. 13(7). 851–870. 67 indexed citations

11.

Patkar, Ashwin A., William Gilmer, Chi‐Un Pae, et al.. (2012). A 6 Week Randomized Double-Blind Placebo-Controlled Trial of Ziprasidone for the Acute Depressive Mixed State. PLoS ONE. 7(4). e34757–e34757. 48 indexed citations

12.

Crisafulli, Concetta, Costanza Andrisano, Chi‐Un Pae, et al.. (2012). Case–control association study of 14 variants of CREB1, CREBBP and CREM on diagnosis and treatment outcome in major depressive disorder and bipolar disorder. Psychiatry Research. 198(1). 39–46. 20 indexed citations

13.

Shin, Cheolmin, Hans‐Jürgen Möller, Chi‐Un Pae, & Ashwin A. Patkar. (2011). Tools for Quality Evaluation of Clinical Research Reports. 22(2). 67–72. 4 indexed citations

14.

Pae, Chi‐Un, Antonio Drago, Jung-Jin Kim, et al.. (2010). TAAR6 variations possibly associated with antidepressant response and suicidal behavior. Psychiatry Research. 180(1). 20–24. 14 indexed citations

15.

Pae, Chi‐Un, et al.. (2009). Desvenlafaxine, a serotonin-norepinephrine uptake inhibitor for major depressive disorder, neuropathic pain and the vasomotor symptoms associated with menopause.. PubMed. 10(1). 75–90. 15 indexed citations

16.

Wu, Li‐Tzy, Christopher L. Ringwalt, Paolo Mannelli, & Ashwin A. Patkar. (2008). Prescription Pain Reliever Abuse and Dependence Among Adolescents: A Nationally Representative Study. Journal of the American Academy of Child & Adolescent Psychiatry. 47(9). 1020–1029. 54 indexed citations

17.

Mandelli, Laura, Byung‐Joo Ham, Prakash S. Masand, et al.. (2008). Do estradiol levels influence on the cognitive function during antidepressant treatments in post-menopausal women with major depressive disorder? A comparison with pre-menopausal women.. PubMed. 29(4). 500–6. 10 indexed citations

18.

Pae, Chi‐Un, et al.. (2007). Quinone oxidoreductase (NQO1) gene polymorphism may not confer a susceptibility to mood disorders. Psychiatry Research. 153(1). 83–86. 4 indexed citations

19.

Pae, Chi‐Un, Hyun Kook Lim, Ashwin A. Patkar, et al.. (2007). Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion. Expert Review of Neurotherapeutics. 7(10). 1251–1263. 55 indexed citations

20.

Patkar, Ashwin A., Chi‐Un Pae, & Prakash S. Masand. (2006). Transdermal Selegiline:The New Generation of Monoamine Oxidase Inhibitors. CNS Spectrums. 11(5). 363–375. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact